Press release | Official website vaccine against COVID-19 Sputnik V.

Main
Newsroom
Press Releases

Press Releases

One-shot Sputnik Light vaccine (first component of the Sputnik V vaccine) demonstrates 70% efficacy against infection with the Delta variant during the first three months after vaccination, Gamaleya Center analysis shows

Press release, 13.10.2021

Sputnik V team statement on fake news in UK media

Press release, 11.10.2021

RDIF is inviting international scientists and scientific institutions to cooperate on research of real-world data/real-world evidence (RWD/RWE) on safety and efficacy of Sputnik V, Sputnik Light and other vaccines against coronavirus

Press release, 07.10.2021

The single-component Sputnik Light vaccine authorized in UAE

Press release, 06.10.2021

A clinical study of the combination of AstraZeneca and Sputnik Light vaccines in Azerbaijan shows strong neutralizing antibodies growth in the majority of participants

Press release, 27.09.2021

The single-component Sputnik Light vaccine authorized in Egypt

Press release, 24.09.2021

The single-component Sputnik Light vaccine authorized in Iran

Press release, 15.09.2021

Sputnik V demonstrates 97.2% efficacy and high safety profile against COVID during the vaccination campaign in Belarus

Press release, 15.09.2021

Study on Sputnik Light (first component of Sputnik V) vaccine’s efficacy among the elderly in Argentina published in EClinicalMedicine journal

Press release, 13.09.2021

The single-component Sputnik Light vaccine authorized in Armenia

Press release, 06.09.2021

3 4 5 6 7